Literature DB >> 23060398

Ischemic preconditioning enhances hepatocyte proliferation in the early phase after ischemia under hemi-hepatectomy in rats.

Li-Ming Jin1, Shui-Fang Jin, Yuan-Xing Liu, Lin Zhou, Hai-Yang Xie, Sheng Yan, Xiao Xu, Shu-Sen Zheng.   

Abstract

BACKGROUND: Ischemia/reperfusion (I/R) injury is an important barrier to liver surgery and transplantation because it impairs remnant liver/reduced-size-graft regeneration. Ischemic preconditioning (IPC), as an effective measure to overcome I/R injury, has been shown to enhance the regenerative capacity of hepatocytes. However, investigations have always focused on regeneration in the late phase after reperfusion. This study aimed to investigate whether IPC enhances hepatocyte proliferation in the early phase after reperfusion and possible underlying mechanisms.
METHODS: A total of 90 rats were divided into three groups: hemi-hepatectomy alone (PHx group), 60 minutes of ischemia plus hemi-hepatectomy (I/R group), and a cycle of 10 minutes of alternating I/R prior to 60 minutes of ischemia plus hemi-hepatectomy (IPC group). Each group was divided into five subgroups sacrificed after 0.5, 2, 6, 12 or 24 hours (n=6/subgroup). Subsequently, serum concentrations of alanine aminotransferase (ALT), aspartate aminotransferase (AST), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) were measured; caspase-3 and proliferating cell nuclear antigen (PCNA) proteins were also determined by Western blotting. Furthermore, PCNA was detected by immunohistochemistry to identify the expression site.
RESULTS: Serum ALT and AST levels after 2-24 hours of reperfusion in the PHx and IPC groups were remarkably decreased compared to the I/R group, and the serum TNF-alpha was relatively lower. A significant increase of serum IL-6 levels was found in the PHx and IPC groups compared with the I/R group at each time point. Furthermore, PCNA expression was remarkably increased in the IPC group after 6-12 hours of reperfusion, and in the earlier 0.5 and 6 hours time points after reperfusion have shown the massive PCNA-positive hepatocytes. At the same time, the expression of liver p-JNK was higher in the IPC group in the early phase after reperfusion than that of the I/R group and its expression was consistent with the PCNA.
CONCLUSION: IPC can initiate hepatocyte proliferation in the early phase after ischemia under hemi-hepatectomy, and may be associated with p-JNK expression and triggered by TNF-alpha/IL-6 signals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23060398     DOI: 10.1016/s1499-3872(12)60217-3

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  5 in total

1.  Effects of melatonin on liver function and lipid peroxidation in a rat model of hepatic ischemia/reperfusion injury.

Authors:  Wen-Sheng Deng; Qing Xu; Y E Liu; Chun-Hui Jiang; Hong Zhou; Lei Gu
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

2.  Ischemic preconditioning affects long-term cell fate through DNA damage-related molecular signaling and altered proliferation.

Authors:  Sorabh Kapoor; Ekaterine Berishvili; Sriram Bandi; Sanjeev Gupta
Journal:  Am J Pathol       Date:  2014-08-13       Impact factor: 4.307

3.  Isolation and Expansion of Hepatic Stem-like Cells from a Healthy Rat Liver and their Efficient Hepatic Differentiation of under Well-defined Vivo Hepatic like Microenvironment in a Multiwell Bioreactor.

Authors:  Shibashish Giri; Ali Acikgöz; Augustinus Bader
Journal:  J Clin Exp Hepatol       Date:  2015-05-15

4.  Interleukin-6 and rs1800796 locus single nucleotide polymorphisms in response to hypoxia/reoxygenation in hepatocytes.

Authors:  Zhaowen Wang; Shaohan Wu; Jianhua Liao; Lin Zhong; Tonghai Xing; Junwei Fan; Zhihai Peng
Journal:  Int J Mol Med       Date:  2016-05-18       Impact factor: 4.101

5.  The effect of Liv-52 on liver ischemia reperfusion damage in rats.

Authors:  Orhan Cimen; Hüseyin Eken; Ferda Keskin Cimen; Arif Burak Cekic; Nezahat Kurt; Asli Ozbek Bilgin; Bahadir Suleyman; Halis Suleyman; Renad Mammadov; Kamil Pehlivanoglu; Eray Kurnaz
Journal:  BMC Pharmacol Toxicol       Date:  2020-01-03       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.